RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Laboratoires Euromedis Stock

Laboratoires Euromedis ROCE 2024

Laboratoires Euromedis ROCE

-0.39

Ticker

ALEMG.PA

ISIN

FR0000075343

WKN

806302

In 2024, Laboratoires Euromedis's return on capital employed (ROCE) was -0.39, a 145.98% increase from the -0.16 ROCE in the previous year.

Laboratoires Euromedis Aktienanalyse

What does Laboratoires Euromedis do?

The Euromedis Groupe SA is a European company that operates in the field of medical products and services. The company was founded in France in 1990 and has since expanded throughout Europe. Today, Euromedis Groupe SA is an internationally operating company with branches in several European countries. The company's business model is to supply medical products and services to hospitals, clinics, and health centers. The company specializes in products in the field of anesthesia, intensive care, and emergency medicine. The business model is based on implementing medical innovations in practice, thereby improving the quality of medical care. Euromedis Groupe SA is divided into various divisions, including Centralized Procurement, Medical Engineering, and Services. The company offers a comprehensive product portfolio, including ventilators, medical instruments, consumables, infusion pumps, medical pressure measurement systems, surgical instruments, and more. In addition to a wide selection of products, the company also emphasizes customer orientation and flexibility. Euromedis Groupe SA places great importance on ethical behavior and is committed to meeting the highest quality standards in the development and manufacture of its products. The company also maintains constant communication with medical professionals to adapt its products to the current needs of doctors and nurses. Euromedis Groupe SA strives to make its products as environmentally friendly as possible by using sustainable materials and manufacturing processes. In recent years, the company has embraced the challenges of the digital age and is now also engaged in online commerce. Customers can order products and find information about services and news on the company's website, which is designed to be user-friendly and intuitive. In summary, Euromedis Groupe SA is a European company that offers medical products and services. It specializes in anesthesia, intensive care, and emergency medicine products. The company is divided into different divisions and offers a comprehensive product portfolio. Customer orientation and flexibility are a focus. Euromedis Groupe SA values ethical behavior and utilizes sustainable materials and manufacturing processes. With its online commerce, the company is well-prepared for the future. Laboratoires Euromedis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Laboratoires Euromedis's Return on Capital Employed (ROCE)

Laboratoires Euromedis's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Laboratoires Euromedis's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Laboratoires Euromedis's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Laboratoires Euromedis’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Laboratoires Euromedis stock

What is the ROCE (Return on Capital Employed) of Laboratoires Euromedis this year?

The ROCE of Laboratoires Euromedis is -0.39 undefined this year.

How has the ROCE (Return on Capital Employed) of Laboratoires Euromedis developed compared to the previous year?

The ROCE of Laboratoires Euromedis has increased by 145.98% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Laboratoires Euromedis?

A high Return on Capital Employed (ROCE) indicates that Laboratoires Euromedis has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Laboratoires Euromedis?

A low ROCE (Return on Capital Employed) can indicate that Laboratoires Euromedis has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Laboratoires Euromedis impact the company?

An increase in the ROCE of Laboratoires Euromedis can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Laboratoires Euromedis affect the company?

A decrease in ROCE of Laboratoires Euromedis can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Laboratoires Euromedis?

Some factors that can affect Laboratoires Euromedis's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Laboratoires Euromedis so important for investors?

The ROCE of Laboratoires Euromedis is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Laboratoires Euromedis take to improve the ROCE?

To improve the ROCE, Laboratoires Euromedis can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Laboratoires Euromedis pay?

Over the past 12 months, Laboratoires Euromedis paid a dividend of 0.09 EUR . This corresponds to a dividend yield of about 1.93 %. For the coming 12 months, Laboratoires Euromedis is expected to pay a dividend of 0.12 EUR.

What is the dividend yield of Laboratoires Euromedis?

The current dividend yield of Laboratoires Euromedis is 1.93 %.

When does Laboratoires Euromedis pay dividends?

Laboratoires Euromedis pays a quarterly dividend. This is distributed in the months of March, March, March, February.

How secure is the dividend of Laboratoires Euromedis?

Laboratoires Euromedis paid dividends every year for the past 2 years.

What is the dividend of Laboratoires Euromedis?

For the upcoming 12 months, dividends amounting to 0.12 EUR are expected. This corresponds to a dividend yield of 2.47 %.

In which sector is Laboratoires Euromedis located?

Laboratoires Euromedis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratoires Euromedis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratoires Euromedis from 2/2/2017 amounting to 0.09 EUR, you needed to have the stock in your portfolio before the ex-date on 1/31/2017.

When did Laboratoires Euromedis pay the last dividend?

The last dividend was paid out on 2/2/2017.

What was the dividend of Laboratoires Euromedis in the year 2023?

In the year 2023, Laboratoires Euromedis distributed 0 EUR as dividends.

In which currency does Laboratoires Euromedis pay out the dividend?

The dividends of Laboratoires Euromedis are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Laboratoires Euromedis

Our stock analysis for Laboratoires Euromedis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratoires Euromedis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.